Form 4 for MRNA Moderna
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001127602-22-006809 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-25 | 2022-02-23+ | MRNA | Hoge Stephen | Pres | S - Sale+OE | $140.00 | -20.0K | 1.62M | -1% | -$2.80M |
| DM | 2022-02-25 | 2022-02-23+ | MRNA | Hoge Stephen | Pres | M - OptEx | $5.95 | +20.0K | 1.62M | +1% | +$118.9K |
| DM | 2022-02-25 | 2022-02-23+ | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -20.0K | 127.0K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | S | D | 800 | $138.98 | 1,617,191 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.65 to $139.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2022-02-23 | S | D | 2,300 | $137.83 | 1,617,991 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.53 to $138.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2022-02-23 | S | D | 3,698 | $136.80 | 1,620,291 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.32 to $137.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2022-02-23 | S | D | 1,802 | $135.69 | 1,623,989 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.28 to $136.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2022-02-23 | M | A | 10,000 | $0.99 | 1,625,791 | D | — | — | |
| 6 | Common | Common Stock | 2022-02-23 | M | A | 5,000 | $10.90 | 1,615,791 | D | — | — | |
| 7 | Common | Common Stock | 2022-02-23 | S | D | 100 | $139.67 | 1,617,091 | D | — | — | |
| 8 | Common | Common Stock | 2022-02-23 | S | D | 800 | $142.32 | 1,616,091 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.90 to $142.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 9 | Common | Common Stock | 2022-02-23 | S | D | 5,300 | $144.60 | 1,610,791 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.34 to $145.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 10 | Common | Common Stock | 2022-02-24 | M | A | 5,000 | $10.90 | 1,615,791 | D | — | — | |
| 11 | Common | Common Stock | 2022-02-24 | S | D | 5,000 | $139.80 | 1,610,791 | D | — | — | |
| 12 | Common | Common Stock | 2022-02-23 | S | D | 200 | $141.19 | 1,616,891 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.70 to $141.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 13 | Derivative | Stock Option (Right to Buy) | 2022-02-23 | M | D | 5,000 | $0.00 | 131,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F10) This option is fully vested and exercisable. |
| 14 | Derivative | Stock Option (Right to Buy) | 2022-02-23 | M | D | 10,000 | $0.00 | 117,431 | D | $0.99 · — to 2023-08-19 | 10,000 Common Stock | (F10) This option is fully vested and exercisable. |
| 15 | Derivative | Stock Option (Right to Buy) | 2022-02-24 | M | D | 5,000 | $0.00 | 126,972 | D | $10.90 · — to 2026-02-23 | 5,000 Common Stock | (F10) This option is fully vested and exercisable. |